Cargando…

Hyperuricaemia: a marker of increased cardiovascular risk in rheumatic patients: analysis of the ACT-CVD cohort

BACKGROUND: Gout and hyperuricaemia may be associated with increased cardiovascular risk, but analyses in different populations show conflicting results. This study investigates the impact of serum uric acid, inflammation and traditional CV risk parameters on CV event risk in patients with gouty art...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meek, Inger L, Vonkeman, Harald E, van de Laar, Mart AFJ
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042140/ https://www.ncbi.nlm.nih.gov/pubmed/24886363 http://dx.doi.org/10.1186/1471-2474-15-174

Ejemplares similares

Cardiovascular case fatality in rheumatoid arthritis is decreasing; first prospective analysis of a current low disease activity rheumatoid arthritis cohort and review of the literature
por: Meek, Inger L, et al.
Publicado: (2014)

Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks
por: Meek, Inger L., et al.
Publicado: (2010)

Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin
por: Vonkeman, Harald, et al.
Publicado: (2010)

Patient participation in decisions about disease modifying anti-rheumatic drugs: a cross-sectional survey
por: Nota, Ingrid, et al.
Publicado: (2014)

Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study
por: Vonkeman, Harald E, et al.
Publicado: (2007)

Gout and hyperuricaemia: modifiable cardiovascular risk factors?
por: Burnier, Michel
Publicado: (2023)

Working mechanism of a multidimensional computerized adaptive test for fatigue in rheumatoid arthritis
por: Nikolaus, Stephanie, et al.
Publicado: (2015)

Acceptance of New Technology: A Usability Test of a Computerized Adaptive Test for Fatigue in Rheumatoid Arthritis
por: Nikolaus, Stephanie, et al.
Publicado: (2014)

Development and preliminary evaluation of a short self-report measure of generalized pain hypersensitivity
por: van Bemmel, Peter F, et al.
Publicado: (2019)

Evaluation of a patient decision aid for initiating disease modifying anti-rheumatic drugs
por: Nota, Ingrid, et al.
Publicado: (2016)

Incremental cost effectiveness of proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug ulcers: a pharmacoeconomic analysis linked to a case-control study
por: Vonkeman, Harald E, et al.
Publicado: (2008)

Impact of patient-accessible electronic medical records in rheumatology: use, satisfaction and effects on empowerment among patients
por: van der Vaart, Rosalie, et al.
Publicado: (2014)

How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis
por: Siemons, Liseth, et al.
Publicado: (2014)

The Management of Hyperuricaemia
por: Bayliss, Richard, et al.
Publicado: (1984)

Hyperuricaemia in Cardiovascular Diseases: A Passive or an Active Player?
por: Katsiki, Niki, et al.
Publicado: (2015)

Risk of dementia in gout and hyperuricaemia: a meta-analysis of cohort studies
por: Pan, Shu-Yue, et al.
Publicado: (2021)

Measuring Actual eHealth Literacy Among Patients With Rheumatic Diseases: a Qualitative Analysis of Problems Encountered Using Health 1.0 and Health 2.0 Applications
por: van der Vaart, Rosalie, et al.
Publicado: (2013)

Development of a web-based patient decision aid for initiating disease modifying anti-rheumatic drugs using user-centred design methods
por: Nota, Ingrid, et al.
Publicado: (2017)

Favipiravir: Hyperuricaemia: case report
Publicado: (2021)

The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality
por: Gustafsson, David, et al.
Publicado: (2013)

A multiethnic association analysis of hyperuricaemia with cardiovascular risk in rural and urban areas in Chinese adults
por: Liu, Leilei, et al.
Publicado: (2021)

Hyperuricaemia and its association with other risk factors for cardiovascular diseases: A population‐based study
por: Yazdi, Farzaneh, et al.
Publicado: (2022)

Advances in the management of malignancy-associated hyperuricaemia.
por: Mahmoud, H. H., et al.
Publicado: (1998)

Evaluating Cardiovascular Disease (CVD) risk scores for participants with known CVD and non-CVD in a multiracial/ethnic Caribbean sample
por: Hosein, Amalia, et al.
Publicado: (2020)

Knowledge of risk factors for diabetes or cardiovascular disease (CVD) is poor among individuals with risk factors for CVD
por: Kilkenny, Monique F., et al.
Publicado: (2017)

Hyperuricaemia and the metabolic syndrome in type 2 DM
por: Ogbera, Anthonia O, et al.
Publicado: (2010)

The first metatarsophalangeal joint in gout and asymptomatic hyperuricaemia
por: Stewart, Sarah, et al.
Publicado: (2015)

Hyperuricaemia, gout and allopurinol in the CKD Queensland registry
por: Jeyaruban, A., et al.
Publicado: (2021)

Function of Uric Acid Transporters and Their Inhibitors in Hyperuricaemia
por: Sun, Hao-lu, et al.
Publicado: (2021)

A goal management intervention for polyarthritis patients: rationale and design of a randomized controlled trial
por: Arends, Roos Y, et al.
Publicado: (2013)

AB006. Erectile dysfunction (ED) as a marker for cardiovascular diseases (CVD)
por: Torres, Luiz Otavio
Publicado: (2015)

Association between dyslipidaemia and the risk of hyperuricaemia: a six-year longitudinal cohort study of elderly individuals in China
por: Xu, Ying, et al.
Publicado: (2022)

Construct validity of the interview Time Trade-Off and computer Time Trade-Off in patients with rheumatoid arthritis: A cross-sectional observational pilot study
por: Buitinga, Laurien, et al.
Publicado: (2012)

Telemedicine for patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic; a positive experience in the Netherlands
por: Bos, Wouter H., et al.
Publicado: (2021)

Incident gout and erectile dysfunction: is hyperuricaemia the elephant in the room?
por: Abhishek, Abhishek, et al.
Publicado: (2017)

Hyperuricaemia: prevalence and association with mortality in an elderly Finnish population
por: Timsans, Janis, et al.
Publicado: (2023)

Cost-effectiveness of implementing risk-based cardiovascular disease (CVD) management using updated WHO CVD risk prediction charts in India
por: Sivanantham, Parthibane, et al.
Publicado: (2023)

Temporal trends in hyperuricaemia in the Irish health system from 2006-2014: A cohort study
por: Kumar A. U., Arun, et al.
Publicado: (2018)

Alterations of the Gut Microbiome Associated With the Treatment of Hyperuricaemia in Male Rats
por: Yu, Yiran, et al.
Publicado: (2018)

Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options
por: Bardin, Thomas, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m5b1vt40v00i3qlpn05fhfmoie